Pramipexole Dihydrochloride Tablet
Product Images NDC 57237-183

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 57237-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.125 mg (90 Tablet Bottle))

This is a description of Rising® Npc57237-180-% Pramipexole Dihydrochloride Tablets. It is a medication that comes in a container of 90 tablets with each tablet containing 0.125 mg pramipexole dinydrochioride. The tablets are dispensed in a tight, light-resistant container and should be stored at 20° to 25°C (68° to 77°F) to protect them from light. The medication should only be used as directed in the accompanying prescribing information and kept out of reach of children. It is distributed by Rising Health, LLC in Saddle Brook, NJ 07663 and is made in India. The code for the drug is TS/DRUGS/22/2009 and was last revised in 05/2020.*

FDA Label Image

Package Label-principal Display Panel (0.25 mg (90 Tablet Bottle))

These are Pramipexole Dihydrochloride Tablets containing 0.25 mg of Pramipexole Dinydrochloride Monohydrate equivalent to 0.235 mg Pramipexole Dinydrochloride USP. They come in a container to be stored at 20° to 25°C and protected from light. The instructions advise reading the accompanying prescribing information and keeping them away from children. These are distributed by Rising Health, LLC in Saddle Brook, NJ 07663, and made in India. The code is TS/DRUGS/22/2009, and the latest revision is 05/2020.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg (90 Tablet Bottle))

Rising is a medication containing Pramipexole Dihydrochloride in tablet form. Each tablet contains 0.5 mg of pramipexole dinydrochloride monohydrate equivalent to 0.47 mg pramipexole dinydrochloride USP. It is dispensed in a tight, light-resistant container and the usual dosage should be read on accompanying prescribing information. The medication should be stored in a controlled room temperature of 20° to 25°C (68° to 77°F) and protected from light. It is important to keep out of reach of children. The medication is distributed by Rising Health, LLC in Saddle Brook, NJ and is made in India. No additional information is provided.*

FDA Label Image

Package Label-principal Display Panel (0.75 mg (90 Tablet Bottle))

This is a description of a medication called Pramipexole Dihydrochloride. It is distributed by Rising Health LLC, and each tablet contains 0.75mg of the medication. It is important to read the accompanying prescribing information before taking this medication. The medication should be stored at a temperature of 20-25°C (68°F to 77°F) and protected from light. The medication should be kept out of reach of children. It is not clear what the text refers to with the mention of "Coding Area" and "Dattd line ot 0 b printed".*

FDA Label Image

Package Label-principal Display Panel (1 mg (90 Tablet Bottle))

Rising Pramipexole Dihydrochloride Monohydrate Tablets are a prescription drug that contains 1 mg of Pramipexole Dihydrochloride USP. It is used to treat symptoms of Parkinson's disease, such as tremors and muscle stiffness. Each tablet is equivalent to 0.94 mg of Pramipexole Dihydrochloride. The medicine should be dispensed in a tightly-sealed container and stored at a controlled room temperature of 20-25°C to protect it from light. The usual dosage information should be read through the accompanying prescribing information. This drug is manufactured and distributed by Rising Health, LLC.*

FDA Label Image

Package Label-principal Display Panel (1.5 mg (90 Tablet Bottle))

Rising Health's Pramipexole Dihydrochloride Monohydrate tablets are distributed in a bottle containing 90 tablets, with each tablet containing 1.5 mg of the active ingredient. The tablets come in tight, light-resistant packaging and should be stored between 20°C to 25°C (68°F to 77°F) to protect them from light. However, the dosage should be confirmed by reading the prescribing information accompanying the tablets. The medication should be kept out of the reach of children. No further information is available due to the technical nature of the text obtained via .*

FDA Label Image

Chemical Structure (Pramipexole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.